219 related articles for article (PubMed ID: 2480424)
1. Alpha-fetoprotein in the management of germ cell tumors of the ovary.
Bonazzi C; Colombo N; Lissoni A; Pittelli MR; Bini S; Mangioni C
J Nucl Med Allied Sci; 1989; 33(3 Suppl):53-8. PubMed ID: 2480424
[TBL] [Abstract][Full Text] [Related]
2. Current management of malignant germ cell tumor of the ovary.
Aziz MF
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
[TBL] [Abstract][Full Text] [Related]
4. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
5. [Cisplatin, vinblastine, and bleomycin combination chemotherapy in a stage IV pure endodermal sinus tumor of the ovary--a case report of a long-term survival].
Saito N; Kashimura Y; Soh T; Tsukamoto N
Gan No Rinsho; 1988 Dec; 34(15):2114-8. PubMed ID: 2466134
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy in the management of ovarian germ cell malignancies.
Schwartz PE
Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
[TBL] [Abstract][Full Text] [Related]
7. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
Grischke EM; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
[TBL] [Abstract][Full Text] [Related]
9. Malignant mixed germ cell tumors of the ovary. A clinical and pathologic analysis of 30 cases.
Kurman RJ; Norris HJ
Obstet Gynecol; 1976 Nov; 48(5):579-89. PubMed ID: 185553
[TBL] [Abstract][Full Text] [Related]
10. Second-look laparotomy in endodermal sinus tumor: a report of two patients with normal levels of alpha-fetoprotein and residual tumor at reexploration.
Curtin JP; Rubin SC; Hoskins WJ; Hakes TB; Lewis JL
Obstet Gynecol; 1989 May; 73(5 Pt 2):893-5. PubMed ID: 2468119
[TBL] [Abstract][Full Text] [Related]
11. [The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors].
Calaminus G; Vesterling-Hörner D; Bökkerink JP; Gadner H; Günther G; Haas HJ; Jürgens H; Teske C; Göbel U
Klin Padiatr; 1991; 203(4):246-50. PubMed ID: 1719268
[TBL] [Abstract][Full Text] [Related]
12. Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary.
Rebischung C; Pautier P; Morice P; Lhomme C; Duvillard P
Gynecol Oncol; 2000 Apr; 77(1):203-5. PubMed ID: 10739713
[TBL] [Abstract][Full Text] [Related]
13. The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
Ballas M
Ann Clin Lab Sci; 1974; 4(4):267-75. PubMed ID: 4142543
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
[TBL] [Abstract][Full Text] [Related]
15. Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
Toner GC; Geller NL; Tan C; Nisselbaum J; Bosl GJ
Cancer Res; 1990 Sep; 50(18):5904-10. PubMed ID: 1697503
[TBL] [Abstract][Full Text] [Related]
16. Mixed germ cell tumors of the ovary.
Gershenson DM; Del Junco G; Copeland LJ; Rutledge FN
Obstet Gynecol; 1984 Aug; 64(2):200-6. PubMed ID: 6204258
[TBL] [Abstract][Full Text] [Related]
17. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients.
Bonazzi C; Peccatori F; Colombo N; Lucchini V; Cantù MG; Mangioni C
Obstet Gynecol; 1994 Oct; 84(4):598-604. PubMed ID: 7522313
[TBL] [Abstract][Full Text] [Related]
18. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
19. [Modified VAB-3 combination chemotherapy of stage IV endodermal sinus tumor of the ovary].
Tsukamoto N; Imachi M; Sumioki H; Kamura T
Gan To Kagaku Ryoho; 1984 Apr; 11(4):948-51. PubMed ID: 6202244
[TBL] [Abstract][Full Text] [Related]
20. Laparotomy for post chemotherapy residue in ovarian germ cell tumors.
Mathew GK; Singh SS; Swaminathan RG; Tenali SG
J Postgrad Med; 2006; 52(4):262-5. PubMed ID: 17102543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
